Investigating incoherence gives insight: Clopidogrel is equivalent to extended-release dipyridamole plus aspirin in secondary stroke prevention

Journal of Clinical Epidemiology

Volumn 65, Issue 8, 2012, Pages 835-845

  Dewilde, Sarah ^a   Hawkins, Neil ^b  

^a Services in Health Economics   (Belgium)

^b ICON PLC   (United Kingdom)

Author keywords

Aspirin; Clopidogrel; Dipyridamole; Incoherence; Indirect comparison; Network meta analysis

Indexed keywords

ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; CLOPIDOGREL;

ANTICOAGULANT THERAPY; ARTICLE; DOSE RESPONSE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL MODEL; STROKE; SYSTEMATIC REVIEW;

EID: 84862880722     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2012.01.019     Document Type: Review

References (18)

1. Lu GA, Ades AE. Assessing evidence inconsistency in mixed treatment comparisons. J Am Stat Assoc 2006;101:447-59. (Pubitemid 43972289)
2. Kent DM, Thaler DE. Stroke prevention - insights from incoherence. N Engl J Med 2008;359:1287-9.
3. Glenny AM, Altman DG, Song F, Sakarovitch C, Deeks JJ, D'Amico R, et al. Indirect comparisons of competing interventions. Health Technol Assess 2005;9:1-134.
4. The ESPRIT Study Group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006;367:1665e73. [Erratum, Lancet 2007;369:274.].
5. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.
6. Thijs V, Lemmens R, Fieuws S. Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke. Eur Heart J 2008;29:1086-92. (Pubitemid 351844879)
7. Hankey GK, Eikelboom JW. What do the results of the PRoFESS trial teach us? Lancet 2008;7:860-2.
8. Verro P, Gorelick PB, Nguyen D. Aspirin plus dipyridamole versus aspirin for the prevention of vascular events after stroke or TIA: a meta-analysis. Stroke 2008;39:1358-63. (Pubitemid 351440719)
9. Diener HC, Sacco R, Yusuf S, Steering Committee, PRoFESS Study Group. Rationale, design and baseline data of a randomized, doubleblind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASAwith clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS). Cerebrovasc Dis 2007;23:368-80. (Pubitemid 46742325)
10. Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, et al, PRoFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008;359:1238-51.
11. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, et al MATCH Investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial. Lancet 2004;364:331-7.
12. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, et al CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-17.
13. Bhatt DL, Flather MD, Hacke W, Berger PB, Black HR, Boden WE, et al CHARISMA Investigators. Patients with prior myocardial infarction, stroke or symptomatic peripheral artery disease in the CHARISMA trial. J Am Coll Cardiol 2007;49:1982-8. (Pubitemid 46694290)
14. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13. (Pubitemid 26402780)
15. Song F, Altman DG, Glenny AM, Deeks JJ. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ 2003;326: 472-6.
16. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324:71-86.
17. Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison analysis. Stat Med 2010;29:932-44.
18. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 2004;23:3105-24. (Pubitemid 39334902)